Solan Headlines

Perfusion Systems Market is Estimated to Value $183.8 Million by 2025: Grand View Research, Inc

 Breaking News
  • No posts were found

Perfusion Systems Market is Estimated to Value $183.8 Million by 2025: Grand View Research, Inc

August 27
23:06 2019
Perfusion Systems Market is Estimated to Value $183.8 Million by 2025: Grand View Research, Inc

Grand View Research, Inc. – Market Research And Consulting.
According to report published by Grand View Research, The global perfusion system market size was valued at USD 87.05 million in 2016 and is expected to witness a CAGR of 8.7% during the forecast period.

The global Perfusion Systems Market is expected to reach USD 183.8 million by 2025, according to a new report by Grand View Research, Inc. Rising demand for transplantation owing to increased incidence of vital organ failures is a major growth driver of the market. To curb this problem, Machine Perfusion (MP) is adopted by clinics. Hence, demand for the same is expected to grow over the coming years.

Statistics published by the National Kidney Foundation in 2014 states that 4,761 patients died due to unavailability of a kidney. This showcases the need for viable donated organs for transplantation, thereby boosting market growth.

The introduction of technologically advanced products for the purpose of enhanced efficiency and cost-effectiveness is expected to serve this market with lucrative opportunities. For instance, introduction of portable organ perfusion systems is presumed to gain popularity over the coming years owing to associated benefits with its usage such as ease of access, cost-efficiency, and portability.

Market participants are involved in extensive R&D for development of innovative perfusion techniques. For instance, TransMedics, Inc. carried out the world’s first warm blood perfusion liver transplantation with its innovative TransMedics Organ Care System Liver technology.

Moreover, many of market players in the U.S. and Europe are involved in the development of new products that are in clinical trials. For example, METRA developed by OrganOx Ltd. for automatic liver transportation and normothermic liver perfusion is under clinical study in the U.S. The expected product approvals in the coming years are anticipated to serve this industry with lucrative growth opportunities.

U.S. perfusion system market, by technology, 2014 – 2025 (USD million)

U.S. perfusion system market

Request a sample Copy of the Global Perfusion System Market Research Report @

Further Key Findings From the Study Suggest: 

  • Presence of government initiatives such as National Organ Transplant Programme in India and initiatives from nonprofit organizations such as Donate Life America in the U.S. are contributing toward increasing awareness level
  • Introduction of warm blood perfusion technology is expected to offer this industry with future growth opportunities
  • Hypothermic MP held the dominant share as of 2016 owing to increasing adoption for kidney preservation. These systems are capable of preserving an organ for a longer duration as compared to static cold storage. The associated benefits with the use of this technology is expected to fuel the demand
  • The MP technology for kidney transplantation segment held a dominant share as of 2016 owing to benefits attached to its usage
  • As of now, there are two MP systems that are approved by the U.S. FDA including LifePort Kidney Transporter by Organ Recovery Systems Inc. and WAVES RM3 by Waters Medical Systems
  • The Asia Pacific regional industry for MP is expected to witness lucrative CAGR during the forecast period
  • The industry participants are focusing toward the development of cost-effective solutions, thereby increasing R&D activities for the development of novel technologies

Global perfusion system market revenue, by region, 2016 (%)

Global perfusion system market

Have Any Query? Ask Our Experts @

Grand View Research has segmented the perfusion systems market on the basis of the technology, organ type, and region:

Perfusion Technology Outlook (Revenue, USD Million, 2014 – 2025)

  • Hypothermic
  • Normothermic

Perfusion Organ Type Outlook (Revenue, USD Million, 2014 – 2025)

  • Heart
  • Lung
  • Kidney
  • Liver
  • Others

Perfusion Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • South Africa

Browse Related Report:

Non-vascular Stents Market –

Hernia Mesh Devices Market –

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States

Related Articles